Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing palonosetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Palonosetron hydrochloride (substance) |
Is a |
False |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Palonosetron 0.25mg/5mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing netupitant and palonosetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Netupitant- and palonosetron-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely palonosetron (as palonosetron hydrochloride) 250 microgram/5 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Palonosetron hydrochloride (substance) |
Is modification of (attribute) |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Palonosetron-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only netupitant and palonosetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only palonosetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only netupitant and palonosetron in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only palonosetron in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing fosnetupitant and palonosetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only fosnetupitant and palonosetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing fosnetupitant and palonosetron in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fosnetupitant and palonosetron only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fosnetupitant and palonosetron only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fosnetupitant- and palonosetron-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Palonosetron (as palonosetron hydrochloride) 50 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule |
Has basis of strength substance (attribute) |
True |
Palonosetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |